Edition:
United States

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

7.37USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$7.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
74,712
52-wk High
$9.22
52-wk Low
$3.76

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 27.18 -0.002
Jun '17 3.52 -0.036
Mar '17 2.86 -0.051
FY 2016 Dec '16 8.54 -0.036
Sep '16 2.42 -0.044
Jun '16 0.33 -0.052
Mar '16 2.92 -0.037
FY 2015 Dec '15 2.78 -0.053
Mar '15 2.73 -0.046
Dec
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 7 8.56 22.00 0.00 10.68
Quarter Ending Mar-18 5 11.43 22.00 4.00 11.47
Year Ending Dec-17 7 41.50 51.00 33.60 22.49
Year Ending Dec-18 7 52.40 88.00 32.50 37.69
Earnings (per share)
Quarter Ending Dec-17 6 -0.23 -0.09 -0.32 -0.34
Quarter Ending Mar-18 5 -0.21 -0.10 -0.25 -0.23
Year Ending Dec-17 6 -0.75 -0.61 -0.94 -1.17
Year Ending Dec-18 6 -0.81 -0.39 -1.29 -1.12
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta -- 0.82 0.91
Price to Sales (TTM) 16.40 122.78 5.95
Price to Book (MRQ) 3.02 23.45 5.68
Price to Tangible Book (MRQ) 3.03 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 61.50 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,025.21 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -- 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 96.42 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 3.70 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -- -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -145.03 -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -155.86 -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -135.95 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -138.46 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 141,272 22,314,532 851,801,741
Net Income/Employee (TTM) -195,601 -1,997,855 99,542,701
Receivable Turnover (TTM) 20.72 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.16 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -22.25 -9.39 11.31
Return on Assets - 5 Yr. Avg. -- 0.28 12.28
Return on Investment (TTM) -26.94 -11.76 14.43
Return on Investment - 5 Yr. Avg. -- 3.42 16.07
Return on Equity (TTM) -28.50 -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Adaptimmune Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -6.47 -9.86 32 94
13 Week -15.96 -21.48 29 75
26 Week 61.27 46.64 88 59
52 Week 96.01 65.70 85 58
YTD 81.98 52.26 84 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 61.50%
# of Holders: 67
Total Shares Held: 57,620,832
3 Mo. Net Change: 2,664,498
# New Positions: 16
# Closed Positions: 6
# Increased Positions: 38
# Reduced Positions: 20
# Net Buyers: 18
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.